About
4.52USD-0.02 -0.44%
Closed • Updated at 21:57 GMT+00:00Market Cap$631.28M
Volume627.7K
Beta1.06
RSI51.47
Gross Margin9.69%
Aclaris Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
May 7 2026
Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Apr 28 2026
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indicati...
Apr 27 2026
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
Apr 8 2026
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
Community Chat
Ask AI
Try asking
Translate